CME Group Inc. Form 8-K Summary
Business Context and Reporting Period
CME Group Inc. filed this Current Report on Form 8-K on February 14, 2019, to announce its financial results for the quarter ended December 31, 2018. The filing incorporates by reference a press release (Exhibit 99.1) detailing the company's performance.
Key Financial Metrics
The filing text itself does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These figures are contained within the attached press release (Exhibit 99.1), which is not included in the provided source text. The company reports both GAAP and non-GAAP financial measures, including non-GAAP net income and earnings per share, to supplement GAAP results.
Material Changes
The filing text does not explicitly detail material changes versus the prior comparable period. It notes that management believes the non-GAAP measures provide better comparability with prior financial reports, but specific variance data is absent from the 8-K body text.
Guidance, Outlook, and Risks
The filing includes a standard disclaimer that the information in Item 2.02 and the attached press release is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934. Management acknowledges that non-GAAP adjustments may include recurring items and emphasizes that these measures are supplements to, not substitutes for, GAAP measures. No specific forward-looking guidance or risk factors are detailed in the 8-K text provided.
Investor Verification Checklist
- Review the attached press release (Exhibit 99.1) for specific Q4 2018 revenue, net income, and earnings per share figures.
- Examine the reconciliation of non-GAAP financial measures to GAAP measures included in the press release.
- Verify the specific components of non-GAAP adjustments to understand recurring items excluded from GAAP results.
- Compare the reported Q4 2018 results against the Q4 2017 period as detailed in the full press release.